Skip to main content
Year archive

Orexo — 2017 filings

All 28 regulatory filings released by Orexo (ORX) in 2017, sourced directly from the official regulator.

28 Filings
2017 Period
2017 filings (28)
Filing Released Lang
Orexo offentliggör en villkorad fullständig inlösen av dess seniora icke-säkerställda obligationer
Capital/Financing Update
2017-10-27 Swedish
Orexo announces conditional total redemption of its senior unsecured bonds
Capital/Financing Update
2017-10-27 English
Earnings Release 2017
Earnings Release Q3 2017
2017-10-19 Swedish
Interim / Quarterly Report 2017
Interim / Quarterly Report Q3 2017
2017-10-19 English
Orexo signs asset purchase agreement with Gesynta Pharma AB for OX-MPI
M&A Activity
2017-10-02 English
Orexo tecknar förvärvsavtal med Gesynta Pharma AB avseende OX-MPI
M&A Activity
2017-10-02 Swedish
Positivt CHMP utlåtande för behandling av opioidberoende med Zubsolv® (buprenorfin och naloxon) i Europa
Regulatory Filings
2017-09-15 Swedish
CHMP positive opinion for opioid dependence treatment with Zubsolv® (buprenorphine and naloxone) in Europe
Regulatory Filings
2017-09-15 English
Interim / Quarterly Report 2017
Interim / Quarterly Report Q2 2017
2017-07-11 Swedish
Interim / Quarterly Report 2017
Interim / Quarterly Report Q2 2017
2017-07-11 English
Number of shares and votes in Orexo
Share Issue/Capital Change
2017-06-30 English
Antal aktier och röster i Orexo
Declaration of Voting Results & Voting Rights Announcements
2017-06-30 Swedish
Issue and repurchase of class C shares
Transaction in Own Shares
2017-06-16 English
Emission och återköp av C-aktier
Share Issue/Capital Change
2017-06-16 Swedish
Orexo receives USD 2.5 million milestone payment from AstraZeneca as OX-CLI advances into clinical trials
Regulatory Filings
2017-06-02 English
Orexo erhåller en delmålsbetalning på USD 2,5 miljoner från AstraZeneca till följd av att OX-CLI går in i klinisk fas
Legal Proceedings Report
2017-06-02 Swedish
Interim / Quarterly Report 2017
Interim / Quarterly Report Q1 2017
2017-04-20 Swedish
Interim / Quarterly Report 2017
Interim / Quarterly Report Q1 2017
2017-04-20 English
Report from Orexo AB´s annual general meeting, April 6 2017
AGM Information
2017-04-06 English
Kommuniké från Orexo AB:s årsstämma den 6 april 2017
AGM Information
2017-04-06 Swedish
Annual Report 2016
Annual Report FY 2016
2017-03-16 Swedish
Annual Report 2016
Annual Report FY 2016
2017-03-16 English
Notice of Annual General Meeting of Orexo
AGM Information
2017-03-07 English
Kallelse till årsstämma i Orexo
AGM Information
2017-03-07 Swedish
Orexo stämmer Actavis för patentintrång avseende deras generiska versioner av Suboxone® och Subutex® tabletter i USA
Legal Proceedings Report
2017-03-01 Swedish
Orexo commences patent infringement litigation against Actavis for their generic versions of Suboxone® and Subutex® tablets in the US
Legal Proceedings Report
2017-03-01 English
Interim / Quarterly Report 2016
Interim / Quarterly Report FY 2016
2017-01-26 Swedish
Interim / Quarterly Report 2016
Interim / Quarterly Report FY 2016
2017-01-26 English